ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,518Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 2035

$965K Total Retail Price of All Prescriptions

Rank: 54 out of 2035

424 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

29% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 8,141 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LISINOPRIL 540 364 1 3
SIMVASTATIN 524 337 2 1
HYDROCODONE-ACETAMINOPHEN 468 248 S3 3 2
NEXIUM 438 196 4 51
OMEPRAZOLE 395 261 5 5
METFORMIN HCL 385 233 6 9
GABAPENTIN 363 189 7 14
ATORVASTATIN CALCIUM 291 201 8 13
LEVOTHYROXINE SODIUM 285 204 9 4
MELOXICAM 235 165 10 56
FLUTICASONE PROPIONATE 228 106 11 29
ADVAIR DISKUS 218 114 12 38
PROAIR HFA 214 114 13 31
IBUPROFEN 211 94 14 43
AZITHROMYCIN 173 84 15 39
VOLTAREN 164 116 16 141
FUROSEMIDE 162 139 17 7
METOPROLOL TARTRATE 154 112 18 8
TRAMADOL HCL 151 74 19 19
TAMSULOSIN HCL 147 113 20 25
CLOPIDOGREL 147 86 20 30
AMLODIPINE BESYLATE 129 107 22 6
METFORMIN HCL ER 124 98 23 78
POLYETHYLENE GLYCOL 3350 122 86 24 48
SINGULAIR 119 43 25 119
ZOLPIDEM TARTRATE 116 52 26 21
PATANOL 116 53 26 233
CELEBREX 114 63 28 104
CLOTRIMAZOLE-BETAMETHASONE 111 55 29 123
LOSARTAN POTASSIUM 109 80 30 15
HYDROCHLOROTHIAZIDE 109 80 30 12
CARVEDILOL 108 84 32 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 82 32 26
PREDNISONE 102 63 34 36
PLAVIX 101 68 35 49
NAPROXEN 101 65 35 92
LYRICA 100 69 37 89
CRESTOR 100 43 37 41
RANITIDINE HCL 96 63 39 28
TRICOR 93 39 40 120
GLYBURIDE-METFORMIN HCL 92 57 R 41 139
TRIAMCINOLONE ACETONIDE 92 68 41 142
JANUVIA 92 72 41 85
WARFARIN SODIUM 85 74 44 11
VENTOLIN HFA 84 23 45 80
NASONEX 83 42 46 207
GLIPIZIDE 81 55 47 54
PATADAY 79 71 48 372
FENOFIBRATE 78 35 49 82
XOPENEX HFA 78 59 49 375
LIPITOR 77 50 51 134
POTASSIUM CHLORIDE 76 60 52 18
ALENDRONATE SODIUM 75 72 53 27
DICYCLOMINE HCL 72 28 54 212
METOPROLOL SUCCINATE 72 37 54 16
CYMBALTA 72 44 54 59
QUETIAPINE FUMARATE 71 24 57 70
PROMETHAZINE HCL 69 34 R 58 106
SERTRALINE HCL 69 23 58 23
MONTELUKAST SODIUM 69 33 58 187
AVODART 68 34 61 225
ATENOLOL 61 43 62 10
LEVOFLOXACIN 59 27 63 99
LANSOPRAZOLE 59 35 63 118
CYCLOBENZAPRINE HCL 58 18 R 65 64
MECLIZINE HCL 57 36 66 147
JANUMET 54 33 67 221
AMLODIPINE BESYLATE-BENAZEPRIL 53 52 68 88
SPIRIVA 53 36 68 44
RISPERIDONE 52 31 70 68
LOVAZA 50 32 71 137
AMITRIPTYLINE HCL 50 18 R 71 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.